NasdaqGM - Nasdaq Real Time Price • USD
Altimmune, Inc. (ALT)
As of 12:00 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 550.15k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ROBERTS M SCOT Officer | -- | Direct | -- | Feb 2, 2024 |
| GARG VIPIN K. Chief Executive Officer | -- | Direct | -- | Feb 2, 2024 |
| HARRIS MATTHEW SCOTT Officer | -- | Direct | -- | Feb 2, 2024 |
| ROBERTS M SCOT Officer | Stock Award(Grant) at price 9.44 per share. | Direct | 55,318 | Jan 31, 2024 |
| EISENSTADT RICHARD I Chief Financial Officer | Stock Award(Grant) at price 9.44 per share. | Direct | 43,622 | Jan 31, 2024 |
| GARG VIPIN K. Chief Executive Officer | Stock Award(Grant) at price 9.44 per share. | Direct | 74,472 | Jan 31, 2024 |
| HARRIS MATTHEW SCOTT Officer | Stock Award(Grant) at price 9.44 per share. | Direct | 30,746 | Jan 31, 2024 |
| JORDT RAYMOND M Officer | Stock Award(Grant) at price 9.44 per share. | Direct | 47,483 | Jan 31, 2024 |
| ROBERTS M SCOT Officer | -- | Direct | -- | Jan 30, 2024 |
| EISENSTADT RICHARD I Chief Financial Officer | -- | Direct | -- | Jan 30, 2024 |
| GARG VIPIN K. Chief Executive Officer | -- | Direct | -- | Jan 30, 2024 |
| HARRIS MATTHEW SCOTT Officer | -- | Direct | -- | Jan 30, 2024 |
| EISENSTADT RICHARD I Chief Financial Officer | -- | Direct | -- | Dec 29, 2023 |
| JORDT RAYMOND M Officer | -- | Direct | -- | Dec 29, 2023 |
| DRUTZ DAVID J Director | Purchase at price 2.88 per share. | Indirect | 862 | Aug 15, 2023 |
| ROBERTS M SCOT Officer | Stock Award(Grant) at price 2.81 per share. | Direct | 1,596 | Jul 31, 2023 |
| EISENSTADT RICHARD I Chief Financial Officer | Stock Award(Grant) at price 2.81 per share. | Direct | 5,128 | Jul 31, 2023 |
| GARG VIPIN K. Chief Executive Officer | Stock Award(Grant) at price 2.81 per share. | Direct | 354 | Jul 31, 2023 |
| HARRIS MATTHEW SCOTT Officer | Stock Award(Grant) at price 2.81 per share. | Direct | 1,942 | Jul 31, 2023 |
| JORDT RAYMOND M Officer | Stock Award(Grant) at price 2.81 per share. | Direct | 5,148 | Jul 31, 2023 |
| EISENSTADT RICHARD I Chief Financial Officer | Purchase at price 4.31 per share. | Direct | 43,140 | Mar 24, 2023 |
| DRUTZ DAVID J Director | Purchase at price 4.27 per share. | Indirect | 38,430 | Mar 23, 2023 |
| HARRIS MATTHEW SCOTT Officer | Purchase at price 4.22 per share. | Direct | 42,200 | Mar 23, 2023 |
| ROBERTS M SCOT Officer | -- | Direct | -- | Feb 2, 2023 |
| GARG VIPIN K. Chief Executive Officer | -- | Direct | -- | Feb 2, 2023 |
| HARRIS MATTHEW SCOTT Officer | -- | Direct | -- | Feb 2, 2023 |
| ROBERTS M SCOT Officer | -- | Direct | -- | Feb 1, 2023 |
| GARG VIPIN K. Chief Executive Officer | -- | Direct | -- | Feb 1, 2023 |
| HARRIS MATTHEW SCOTT Officer | -- | Direct | -- | Feb 1, 2023 |
| ROBERTS M SCOT Officer | Stock Award(Grant) at price 13.64 per share. | Direct | 19,587 | Jan 31, 2023 |
| EISENSTADT RICHARD I Chief Financial Officer | Stock Award(Grant) at price 13.64 per share. | Direct | 15,986 | Jan 31, 2023 |
| GARG VIPIN K. Chief Executive Officer | Stock Award(Grant) at price 13.64 per share. | Direct | 26,434 | Jan 31, 2023 |
| HARRIS MATTHEW SCOTT Officer | Stock Award(Grant) at price 13.64 per share. | Direct | 17,677 | Jan 31, 2023 |
| EISENSTADT RICHARD I Chief Financial Officer | -- | Direct | -- | Dec 30, 2022 |
| PISANO WAYNE Director | Sale at price 15.01 per share. | Direct | 300,268 | Dec 22, 2022 |
| PISANO WAYNE Director | Conversion of Exercise of derivative security at price 2.60 per share. | Direct | 52,000 | Dec 22, 2022 |
| DRUTZ DAVID J Director | Conversion of Exercise of derivative security at price 2.40 per share. | Direct | 334 | Nov 18, 2022 |
| GARG VIPIN K. Chief Executive Officer | Sale at price 20.02 per share. | Direct | 400,322 | Aug 31, 2022 |
| GILL JOHN M Director | Sale at price 15.00 per share. | Direct | 40,710 | Aug 12, 2022 |
| GARG VIPIN K. Chief Executive Officer | Sale at price 15.06 per share. | Direct | 225,890 | Aug 12, 2022 |
| ROBERTS M SCOT Officer | Stock Award(Grant) at price 12.01 per share. | Direct | 8,791 | Jul 29, 2022 |
| EISENSTADT RICHARD I Chief Financial Officer | Stock Award(Grant) at price 12.01 per share. | Direct | 16,406 | Jul 29, 2022 |
| HARRIS MATTHEW SCOTT Officer | Stock Award(Grant) at price 12.01 per share. | Direct | 12,923 | Jul 29, 2022 |
| ROBERTS M SCOT Officer | Sale at price 12.00 per share. | Direct | 445,968 | Jul 5, 2022 |
| ROBERTS M SCOT Officer | Conversion of Exercise of derivative security at price 2.60 - 2.95 per share. | Direct | 80,512 | Jul 5, 2022 |
| ROBERTS M SCOT Officer | Sale at price 12.00 per share. | Direct | 65,546 | Jun 29, 2022 |
| ROBERTS M SCOT Officer | Conversion of Exercise of derivative security at price 2.60 per share. | Direct | 14,201 | Jun 29, 2022 |
| ROBERTS M SCOT Officer | Sale at price 12.00 per share. | Direct | 448,254 | Jun 27, 2022 |
| ROBERTS M SCOT Officer | Conversion of Exercise of derivative security at price 1.92 - 2.60 per share. | Direct | 79,752 | Jun 27, 2022 |
| JORKASKY DIANE K Director | Sale at price 11.75 per share. | Direct | 206,944 | Jun 27, 2022 |
Related Tickers
VKTX Viking Therapeutics, Inc.
67.08
+3.09%
MDGL Madrigal Pharmaceuticals, Inc.
191.99
-6.19%
IOVA Iovance Biotherapeutics, Inc.
11.30
-3.50%
TGTX TG Therapeutics, Inc.
13.67
-2.22%
ANVS Annovis Bio, Inc.
13.33
+4.62%
IBRX ImmunityBio, Inc.
5.03
+4.25%
AXSM Axsome Therapeutics, Inc.
71.70
+0.74%
TERN Terns Pharmaceuticals, Inc.
4.5500
-4.21%
MCRB Seres Therapeutics, Inc.
0.7561
+3.65%
CDTX Cidara Therapeutics, Inc.
13.20
+7.40%